|
시장보고서
상품코드
1961966
반려동물용 의약품 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Companion Animal Pharmaceuticals Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
반려동물 의약품 시장 규모는 2025년 198억 4,000만 달러에서 2034년에는 320억 1,000만 달러에 달할 것으로 예측되며, 2026년부터 2034년까지 CAGR 5.46%로 성장할 전망입니다.
전 세계적으로 반려동물 사육이 지속적으로 증가하면서 반려동물의 건강과 복지에 대한 관심이 높아짐에 따라 반려동물 의약품 시장이 크게 성장할 것으로 예상됩니다. 반려동물을 가족의 일원으로 인식하는 경향이 강해지면서 백신, 구충제, 통증 관리 솔루션 등 동물용 의약품에 대한 수요가 급증하고 있습니다. 이러한 추세는 예방적 건강관리의 중요성과 정기적인 수의사 검진의 필요성에 대한 인식이 높아짐에 따라 더욱 가속화되고 있습니다. 시장이 진화함에 따라 제약사들은 반려동물의 특정 건강 요구를 충족시킬 수 있는 혁신적인 치료법을 개발하기 위해 연구개발에 대한 투자를 강화할 것으로 예상되며, 이를 통해 미래 성장을 위한 탄탄한 궤도를 확보할 수 있을 것으로 보입니다.
또한, 수의학과 기술의 발전으로 반려동물용 의약품의 기능성이 향상되고 있습니다. 표적 치료제와 생물학적 제제의 개발은 치료의 지형을 바꾸고 있으며, 반려동물의 다양한 건강 상태를 보다 효과적이고 안전하게 관리할 수 있는 옵션을 제공하고 있습니다. 또한, 수의학에서 원격의료의 보급은 의약품에 대한 접근을 용이하게 하고, 보호자가 원격으로 수의사와 상담하고 필요한 약을 보다 편리하게 구할 수 있게 해주고 있습니다. 시장이 이러한 기술적 진보에 계속 적응하는 가운데, 혁신과 접근성에 대한 초점이 반려동물 의약품 분야의 성장을 견인할 것입니다.
또한 반려동물의 건강 증진과 예방의학에 대한 관심이 높아지면서 반려동물 의약품 시장에도 영향을 미치고 있습니다. 반려동물의 종합적인 건강과 장수를 촉진하는 제품을 찾는 반려동물 보호자들이 늘어나고 있기 때문입니다. 관절 건강, 피부 및 털 상태, 소화기 건강을 지원하는 건강보조식품 및 보충제는 소비자들 사이에서 인기가 높아지고 있습니다. 시장이 발전함에 따라 의약품과 건강 제품의 통합은 반려동물의 종합적인 건강 요구를 충족시킬 수 있는 새로운 기회를 제공하게 될 것입니다. 혁신성, 접근성, 소비자 교육에 초점을 맞춘 반려동물 의약품 시장의 미래는 유망하며, 반려동물 케어 솔루션 개선의 길을 개척하고 있습니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 반려동물용 의약품 시장 : 동물 유형별
제5장 세계의 반려동물용 의약품 시장 : 투여 경로별
제6장 세계의 반려동물용 의약품 시장 : 제품별
제7장 세계의 반려동물용 의약품 시장 : 약물 종류별
제8장 세계의 반려동물용 의약품 시장 : 유통 채널별
제9장 세계의 반려동물용 의약품 시장 : 지역별
제10장 경쟁 구도
제11장 기업 개요
KSMThe Companion Animal Pharmaceuticals Market size is expected to reach USD 32.01 Billion in 2034 from USD 19.84 Billion (2025) growing at a CAGR of 5.46% during 2026-2034.
The companion animal pharmaceuticals market is poised for significant growth as pet ownership continues to rise globally, leading to an increased focus on the health and well-being of pets. As pet owners increasingly view their animals as family members, the demand for veterinary medicines, including vaccines, anti-parasitics, and pain management solutions, is surging. This trend is further fueled by the growing awareness of preventive healthcare and the importance of regular veterinary check-ups. As the market evolves, pharmaceutical companies are likely to invest in research and development to create innovative treatments that address the specific health needs of companion animals, ensuring a robust trajectory for future growth.
Moreover, advancements in veterinary medicine and technology are enhancing the capabilities of companion animal pharmaceuticals. The development of targeted therapies and biologics is revolutionizing the treatment landscape, offering more effective and safer options for managing various health conditions in pets. Additionally, the rise of telemedicine in veterinary care is facilitating access to pharmaceuticals, allowing pet owners to consult with veterinarians remotely and obtain necessary medications more conveniently. As the market continues to adapt to these technological advancements, the focus on innovation and accessibility will drive growth in the companion animal pharmaceuticals sector.
Furthermore, the increasing emphasis on pet wellness and preventive care is influencing the companion animal pharmaceuticals market, as pet owners seek products that promote overall health and longevity. Nutraceuticals and supplements designed to support joint health, skin and coat condition, and digestive health are gaining popularity among consumers. As the market evolves, the integration of pharmaceuticals with wellness products will create new opportunities for manufacturers to cater to the holistic health needs of companion animals. With a focus on innovation, accessibility, and consumer education, the future of the companion animal pharmaceuticals market looks promising, paving the way for enhanced pet care solutions.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Animal Type
- Dogs
- Cats
- Horses
By Route of Administration
- Oral
- Injectable
- Topical
By Product
- Drugs
- Vaccines
- Medicated Feed Additives
By Drug Class
- Antibiotics
- Anti-inflammatory
- Heart Worm Drugs
- Parasiticides
- Nutritional Drugs
- Behavioral Drugs
- Vaccines
- Others
By Distribution Channel
- Veterinary Hospitals
- Clinics
COMPANIES PROFILED
- Boehringer Ingelheim International GmbH, Ceva, Balchem Corp, Chanelle Pharma, Dechra Pharmaceuticals Limited, Elanco or its affiliates, ECO Animal Health Ltd, Enovis Corporation, Invetx, Merck Co Inc, MP Agro Co Ltd, Neogen Corporation, Norbrook, Orion Corporation, Sumitomo Corporation
We can customise the report as per your requriements
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Animal Type
- 4.2. Dogs Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Cats Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Horses Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Route Of Administration
- 5.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: BY PRODUCT 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Product
- 6.2. Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Medicated Feed Additives Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: BY DRUG CLASS 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast Drug Class
- 7.2. Antibiotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Anti-inflammatory Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Heart Worm Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.5. Parasiticides Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.6. Nutritional Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.7. Behavioral Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.8. Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)
- 8.1. Market Analysis, Insights and Forecast Distribution Channel
- 8.2. Veterinary Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 8.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: BY REGION 2022-2034(USD MN)
- 9.1. Regional Outlook
- 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.2.1 By Animal Type
- 9.2.2 By Route Of Administration
- 9.2.3 By Product
- 9.2.4 By Drug Class
- 9.2.5 By Distribution Channel
- 9.2.6 United States
- 9.2.7 Canada
- 9.2.8 Mexico
- 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.3.1 By Animal Type
- 9.3.2 By Route Of Administration
- 9.3.3 By Product
- 9.3.4 By Drug Class
- 9.3.5 By Distribution Channel
- 9.3.6 United Kingdom
- 9.3.7 France
- 9.3.8 Germany
- 9.3.9 Italy
- 9.3.10 Russia
- 9.3.11 Rest Of Europe
- 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.4.1 By Animal Type
- 9.4.2 By Route Of Administration
- 9.4.3 By Product
- 9.4.4 By Drug Class
- 9.4.5 By Distribution Channel
- 9.4.6 India
- 9.4.7 Japan
- 9.4.8 South Korea
- 9.4.9 Australia
- 9.4.10 South East Asia
- 9.4.11 Rest Of Asia Pacific
- 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.5.1 By Animal Type
- 9.5.2 By Route Of Administration
- 9.5.3 By Product
- 9.5.4 By Drug Class
- 9.5.5 By Distribution Channel
- 9.5.6 Brazil
- 9.5.7 Argentina
- 9.5.8 Peru
- 9.5.9 Chile
- 9.5.10 South East Asia
- 9.5.11 Rest of Latin America
- 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.6.1 By Animal Type
- 9.6.2 By Route Of Administration
- 9.6.3 By Product
- 9.6.4 By Drug Class
- 9.6.5 By Distribution Channel
- 9.6.6 Saudi Arabia
- 9.6.7 UAE
- 9.6.8 Israel
- 9.6.9 South Africa
- 9.6.10 Rest of the Middle East And Africa
Chapter 10. COMPETITIVE LANDSCAPE
- 10.1. Recent Developments
- 10.2. Company Categorization
- 10.3. Supply Chain & Channel Partners (based on availability)
- 10.4. Market Share & Positioning Analysis (based on availability)
- 10.5. Vendor Landscape (based on availability)
- 10.6. Strategy Mapping
Chapter 11. COMPANY PROFILES OF GLOBAL COMPANION ANIMAL PHARMACEUTICALS INDUSTRY
- 11.1. Top Companies Market Share Analysis
- 11.2. Company Profiles
- 11.2.1 Boehringer Ingelheim International GmbH
- 11.2.2 Ceva
- 11.2.3 Balchem Corp
- 11.2.4 Chanelle Pharma
- 11.2.5 Dechra Pharmaceuticals Limited
- 11.2.6 Elanco Or Its Affiliates
- 11.2.7 ECO - Animal Health Ltd
- 11.2.8 Enovis Corporation
- 11.2.9 Invetx
- 11.2.10 Merck & Co. Inc
- 11.2.11 MP Agro Co. Ltd
- 11.2.12 Neogen Corporation
- 11.2.13 Norbrook
- 11.2.14 Orion Corporation
- 11.2.15 Sumitomo Corporation
